HSBC Holdings’s VIROPHARMA INC VPHM Stock Holding History

HSBC Holdings’s Portfolio VPHM Stock Details VPHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-6,657	Closed	-$261K	–	1766
2013 Q3	$261K	Buy	+6,657	New	+$218K	﹤0.01%	1537

Other funds holding VPHM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HSBC Holdings's VPHM Position: Q4 2013 in Review

HSBC Holdings sold out of VIROPHARMA INC (VPHM) in Q4 2013, closing a stake of 6,657 shares — an estimated $261K sold.

HSBC Holdings first reported a position in VPHM in Q3 2013 and held it in 1 quarter. The position peaked at $261K in Q3 2013. 172 funds tracked by Wall St. Rank hold VPHM as of Q4 2013.

HSBC Holdings reported no remaining VIROPHARMA INC position as of Q4 2013 after selling out during the quarter.
HSBC Holdings sold 6,657 VIROPHARMA INC shares in Q4 2013, an estimated $261K.
HSBC Holdings first reported a position in VIROPHARMA INC in Q3 2013 and held it in 1 quarter.
HSBC Holdings's VIROPHARMA INC position peaked at $261K in Q3 2013.
172 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q4 2013.

Based on HSBC Holdings's 13F filing for Q4 2013, filed 14 Feb 2014.